| Literature DB >> 35996724 |
Jing Zhao1,2, Yu Fu3, Yong Wang1, Mingjia Bao3, Huiling Li1, Hongbin Qiu2.
Abstract
Objective: To investigate drug resistance and homology of pathogens that can cause infective diarrhea in East Heilongjiang, China, and provide suitable references for the clinical treatment.Entities:
Keywords: diarrhea; drug resistance; homology; pathogen
Year: 2022 PMID: 35996724 PMCID: PMC9392488 DOI: 10.2147/IDR.S372703
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Serotype of Salmonella
| No. | Serotype | Number of Strains (Strain) | Constituent Ratio (%) |
|---|---|---|---|
| 1 | 16 | 69.56 | |
| 2 | 2 | 8.69 | |
| 3 | 1 | 4.35 | |
| 4 | 1 | 4.35 | |
| 5 | 1 | 4.35 | |
| 6 | 1 | 4.35 | |
| 7 | 1 | 4.35 | |
| Total | 23 | 100 |
Drug Sensitivity of Salmonella
| No. | Antibiotics Name | Abbreviation | Drug Resistance | Intermediary | Sensitive | |||
|---|---|---|---|---|---|---|---|---|
| Number of Strains | Drug Resistance Rate (%) | Number of Strains | Intermediary Rate (%) | Number of Strains | Sensitivity Rate (%) | |||
| 1 | Ampicillin | AMP | 11 | 47.83 | 0 | 0 | 12 | 52.17 |
| 2 | Ampicillin-Sulbactam | AMS | 7 | 30.43 | 3 | 13.04 | 13 | 56.52 |
| 3 | Tetracycline | TET | 11 | 47.83 | 0 | 0 | 12 | 52.17 |
| 4 | Meropenem | MEM | 1 | 4.35 | 0 | 0 | 22 | 95.65 |
| 5 | Polymyxin E | CT | 10 | 43.48 | 13 | 56.52 | 0 | 0 |
| 6 | Ertapenem | ETP | 1 | 4.35 | 2 | 8.70 | 20 | 86.95 |
| 7 | Ceftazidime/ Avibatan | CZA | 1 | 4.35 | 0 | 0 | 22 | 95.65 |
| 8 | Cefotaxime | CTX | 1 | 4.35 | 0 | 0 | 22 | 95.65 |
| 9 | Ceftazidime | CAZ | 0 | 0 | 0 | 0 | 23 | 100 |
| 10 | Ciprofloxacin | CIP | 0 | 0 | 14 | 60.87 | 9 | 39.13 |
| 11 | Azithromycin | AZI | 1 | 4.35 | 0 | 0 | 22 | 95.65 |
| 12 | Chloramphenicol | CHL | 1 | 4.35 | 0 | 0 | 22 | 95.65 |
| 13 | Nalidixic acid | NAL | 13 | 56.52 | 0 | 0 | 10 | 43.48 |
| 14 | Streptomycin | STR | 10 | 43.48 | 1 | 4.35 | 12 | 52.17 |
| 15 | Compound Sulfamethoxazole | SXT | 2 | 8.70 | 0 | 0 | 21 | 91.30 |
| 16 | Amikacin | AMK | 0 | 0 | 0 | 0 | 23 | 100 |
Drug Resistant Spectrum of Salmonella
| Number of Drug Resistant Species | Drug Resistant Spectrum | Number of Strains (Strain) | Drug Resistance Rate (%) |
|---|---|---|---|
| 1 | AZI | 1 | 4.35 (1/23) |
| TET | 2 | 8.70 (2/23) | |
| 2 | CT-NAL | 1 | 4.35 (1/23) |
| TET-CT | 4 | 17.39 (4/23) | |
| AMP-TET | 1 | 4.35 (1/23) | |
| NAL-STR | 1 | 4.35 (1/23) | |
| AMP-NAL | 1 | 4.35 (1/23) | |
| 3 | TET-STR-SXT | 1 | 4.35 (1/23) |
| 4 | MEM-CT-CZA-NAL | 1 | 4.35 (1/23) |
| AMP-TET-NAL-STR | 1 | 4.35 (1/23) | |
| AMP-CT-NAL-STR | 1 | 4.35 (1/23) | |
| AMP-AMS-CT-NAL | 1 | 4.35 (1/23) | |
| AMP-AMS-NAL-STR | 2 | 8.70 (2/23) | |
| 5 | AMP-AMS-CT-NAL-STR | 2 | 8.70 (2/23) |
| 6 | AMP-AMS-TET-ETP-NAL-STR | 1 | 4.35 (1/23) |
| 8 | AMP-AMS-TET-CTX-CHL-NAL-STR-SXT | 1 | 4.35 (1/23) |
Figure 1PFGE fingerprint, serotype and drug resistance spectrum of 22 Salmonella strains.